About this trial
Patient Profile
Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Solid Cancer (any type)
Where’s this trial being run?
Bon Secours Cork, Tallaght University Hospital, St Vincents University Hospital, and Mater Misericordiae University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | MK7339-002 / LYNK-002 |
|---|---|
| Number: | CTRIAL-IE 19-27 |
| Full Title: | A Phase 2 Study of Olaparib Monotherapy in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer |
| Principal Investigator: | Ray McDermott |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: |